INS and cardiovascular disorder: The currently reported study was therefore undertaken to evaluate the effects of Px therapy on insulin responsiveness in patients with stable T2D and cardiovascular disease, and to determine whether its effects on insulin signaling might parallel changes in tissue responsiveness to NO.